Chemical Synthesis of Nucleoside Analogues 2013
DOI: 10.1002/9781118498088.ch17
|View full text |Cite
|
Sign up to set email alerts
|

Isoxazolidinyl Nucleosides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 55 publications
1
4
0
Order By: Relevance
“…The reaction pathway involving lower value of ∆S will be the favored one. The ∆S(3,5) is smaller than ∆S (4,5). This suggests that 3,5-substituted isoxazolidine will be generated from the present cycloaddition reaction, in complete agreement with the experimental findings.…”
Section: -37supporting
confidence: 80%
See 1 more Smart Citation
“…The reaction pathway involving lower value of ∆S will be the favored one. The ∆S(3,5) is smaller than ∆S (4,5). This suggests that 3,5-substituted isoxazolidine will be generated from the present cycloaddition reaction, in complete agreement with the experimental findings.…”
Section: -37supporting
confidence: 80%
“…The first option involved changes in the (2-deoxy)-D-ribofuranose moiety as the inversion of hydroxyl group configuration, their elimination leading to dideoxy-or dideoxy-dydehydro-nucleosides, their substitution/functionalization by various groups or cleavage of the sugar ring leading to acyclic nucleosides. 4 Other deeper structural modifications include the replacement of the oxygen atom by a methylene group, a sulfur or a nitrogen atom, or the additional insertion of a second heteroatom in the sugar moiety. [5][6] In particular, N,O-nucleosides, characterized by the presence of an isoxazolidine system as mimetic of the ribose spacer, have been designed and shown to be endowed with antiviral and/or antitumoral activity.…”
Section: Introductionmentioning
confidence: 99%
“…Some of the tested compounds have proven to be potential antiproliferative drugs at a relatively low concentration . Some of these nucleoside analogues were also tested for their apoptotic pathway activation and were found to activate the caspase cleavage, inducing DNA fragmentation …”
Section: Introductionmentioning
confidence: 99%
“…After incorporation, these nucleoside analogues inhibit the elongation of viral DNA chain, preventing the incorporation of next incoming nucleotide, resulting in termination of the growing viral DNA chain [30]. In the last year, to search new biologically active nucleoside analogues, structural modifications on the sugar moiety and/ or the heterocyclic base of natural nucleosides have been performed in order to overcome the drawbacks mainly due to enzymatic degradation and/or to reduce the toxicity and the cross-resistance problems [31][32][33][34][35][36][37][38][39][40]. Currently, there are eight FDA-approved NRTIs: abacavir (ABC), didanosine (ddI), emtricitabine (FTC), lamivudine (3TC), stavudine (d4T), zalcitabine (ddC), zidovudine (AZT), and tenofovir disoprovil fumarate (TDF), a nucleotide RT inhibitor (Figure1).…”
Section: Introductionmentioning
confidence: 99%